Study of Minnelide™ in Patients With Advanced GI Tumors

NCT01927965 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Gastrointestinal Tumors

Interventions

DRUG: Minnelide™ 001

Sponsor

Minneamrita Therapeutics LLC